促胃肠动力药物研究现状  

Research Status of Gastrointestinal Motility Drugs

作　　者：陈汇鑫 唐建华[1,2] CHEN Hui-xin;TANG Jian-hua(College of Animal Science,Southwest University,Chongqing 402460,China;Chongqing Fangtong Animal Pharmaceutical Co.,Ltd.,Chongqing 402460,China)

机构地区：[1]西南大学动物科学学院,重庆402460 [2]重庆方通动物药业有限公司,重庆402460

出　　处：《中国兽药杂志》2018年第9期75-79,共5页Chinese Journal of Veterinary Drug

摘　　要：胃肠动力迟缓类疾病由于发病特征的不显著,在动物身上并未引起足够的重视,但随着近几年畜牧业的不断发展,其发病率不断升高,对国家已造成了不可估量的损失。从药物机制、临床研究等方面对比阐述了人用及兽用促胃肠动力药物的应用现状,旨在为兽用促胃肠动力药物的研发及兽医临床中的使用提供参考。Due to the insignificant characteristics of gastrointestinal motility,it has not attracted enough attention in animals.However,with the continuous development of animal husbandry in recent years,its incidence has been increasing,which has caused immeasurableness to the country.This article compares the application status of human and veterinary gastrointestinal motility drugs from the aspects of drug mechanism and clinical research,aiming at providing reference for the development of veterinary gastrointestinal motility drugs and their use in veterinary clinic.

关 键 词：促胃肠动力 机制 作用 现状 

分 类 号：S859.79[农业科学—临床兽医学]